Lassa fever in Benin: description of the 2014 and 2016 epidemics and genetic characterization of a new Lassa virus.


Journal

Emerging microbes & infections
ISSN: 2222-1751
Titre abrégé: Emerg Microbes Infect
Pays: United States
ID NLM: 101594885

Informations de publication

Date de publication:
Dec 2020
Historique:
pubmed: 30 7 2020
medline: 13 4 2021
entrez: 30 7 2020
Statut: ppublish

Résumé

We report two outbreaks of Lassa fever that occurred in Benin in 2014 and 2016 with 20 confirmed cases and 50% (10/20) mortality. Benin was not previously considered to be an endemic country for Lassa fever, resulting in a delay to diagnose the disease and its human transmission. Molecular investigations showed the viral genomes to be similar to that of the Togo strain, which is genetically very different from other known strains and confirms the existence of a new lineage. Endemic circulation of Lassa virus in a new territory and the genetic diversity thus confirm that this virus represents a growing threat for West African people. Given the divergence of the Benin strain from the prototypic Josiah Sierra Leone strain frequently used to generate vaccine candidates, the efficacy of vaccine candidates should also be demonstrated with this strain.

Identifiants

pubmed: 32723007
doi: 10.1080/22221751.2020.1796528
pmc: PMC7473144
doi:

Substances chimiques

Antibodies, Viral 0
Immunoglobulin G 0
Immunoglobulin M 0
RNA, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1761-1770

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Références

Lancet Infect Dis. 2019 Dec;19(12):1371-1378
pubmed: 31588039
PLoS Negl Trop Dis. 2016 Sep 02;10(9):e0004957
pubmed: 27588425
Emerg Infect Dis. 2013 Nov;19(11):1832-5
pubmed: 24188212
Nature. 1970 Jul 11;227(5254):174
pubmed: 5428406
Mol Biol Evol. 2012 Aug;29(8):1969-73
pubmed: 22367748
BMJ. 1995 Sep 30;311(7009):857-9
pubmed: 7580496
PLoS Negl Trop Dis. 2009;3(3):e388
pubmed: 19255625
Antiviral Res. 2008 Apr;78(1):103-15
pubmed: 18241935
Afr J Lab Med. 2019 Aug 22;8(1):803
pubmed: 31534915
Am J Trop Med Hyg. 1970 Jul;19(4):670-6
pubmed: 4246571
J Vector Borne Dis. 2007 Mar;44(1):1-11
pubmed: 17378212
J Virol. 2011 Nov;85(22):12093-7
pubmed: 21880754
Vector Borne Zoonotic Dis. 2001 Winter;1(4):269-81
pubmed: 12653127
Trans R Soc Trop Med Hyg. 2015 Aug;109(8):483-92
pubmed: 26085474
Trans R Soc Trop Med Hyg. 2007 Dec;101(12):1253-64
pubmed: 17905372
Lancet. 2017 Dec 16;390(10113):2662-2672
pubmed: 29031848
J Virol. 2000 Aug;74(15):6992-7004
pubmed: 10888638
Emerg Infect Dis. 2010 Jul;16(7):1123-6
pubmed: 20587185
Emerg Infect Dis. 2018 Mar;24(3):599-602
pubmed: 29460758
Biology (Basel). 2020 Feb 07;9(2):
pubmed: 32046182
Curr Top Microbiol Immunol. 2002;262:75-109
pubmed: 11987809
J Clin Microbiol. 2010 Jun;48(6):2009-13
pubmed: 20351210
Emerg Infect Dis. 2016 Apr;22(4):694-7
pubmed: 26982388
Front Microbiol. 2015 Oct 01;6:1037
pubmed: 26483768
Emerg Infect Dis. 2019 Oct;25(10):1977-1979
pubmed: 31365854
Cell. 2015 Aug 13;162(4):738-50
pubmed: 26276630
PLoS Negl Trop Dis. 2012;6(9):e1839
pubmed: 23029594
Emerg Infect Dis. 2000 Sep-Oct;6(5):466-76
pubmed: 10998376
BMC Infect Dis. 2018 Dec 17;18(1):667
pubmed: 30558538
Sci Rep. 2016 May 03;6:25280
pubmed: 27140942

Auteurs

Anges Yadouleton (A)

Laboratoire des Fièvres Hémorragiques Virales, Cotonou, Benin.

Caroline Picard (C)

Virology Department, Institut Pasteur CNR des fièvres hémorragiques virales (CNR FHV), Lyon, France.

Toni Rieger (T)

Virology Department, Bernhard-Nocht Institute for Tropical Medicine, Hamburg, Germany.

Frederic Loko (F)

Ministry of Health, Cotonou, Benin.

Daniel Cadar (D)

Virology Department, Bernhard-Nocht Institute for Tropical Medicine, Hamburg, Germany.

Emile Cossi Kouthon (EC)

Hospital St Martin de Papané, Papané, Benin.

Emmanuel Obolli Job (EO)

Sanitary Coordination, Tchaourou, Benin.

Honoré Bankolé (H)

Ministry of Health, Cotonou, Benin.

Lisa Oestereich (L)

Virology Department, Bernhard-Nocht Institute for Tropical Medicine, Hamburg, Germany.

Fernand Gbaguidi (F)

University of Abomey-Calavi, Cotonou, Benin.

Meike Pahlman (M)

Virology Department, Bernhard-Nocht Institute for Tropical Medicine, Hamburg, Germany.

Beate Becker-Ziaja (B)

Virology Department, Bernhard-Nocht Institute for Tropical Medicine, Hamburg, Germany.

Alexandra Journeaux (A)

Laboratoire des Fièvres Hémorragiques Virales, Cotonou, Benin.

Delphine Pannetier (D)

INSERM - Jean Mérieux BSL4Laboratory, CNR FHV, Lyon, France.

Stéphane Mély (S)

INSERM - Jean Mérieux BSL4Laboratory, CNR FHV, Lyon, France.

Stéphanie Mundweiler (S)

INSERM - Jean Mérieux BSL4Laboratory, CNR FHV, Lyon, France.

Damien Thomas (D)

INSERM - Jean Mérieux BSL4Laboratory, CNR FHV, Lyon, France.

Leon Kohossi (L)

World Health Organization, Cotonou, Benin.

Raoul Saizonou (R)

World Health Organization, Cotonou, Benin.

Clement Glele Kakaï (CG)

World Health Organization, Cotonou, Benin.

Magloire Da Silva (M)

Ministry of Health, Cotonou, Benin.

Sonia Kossoubedie (S)

World Health Organization, Cotonou, Benin.

André Lukusa Kakonku (AL)

World Health Organization, Cotonou, Benin.

Pierre M'Pelé (P)

World Health Organization, Cotonou, Benin.

Stephan Gunther (S)

Virology Department, Bernhard-Nocht Institute for Tropical Medicine, Hamburg, Germany.

Sylvain Baize (S)

Laboratoire des Fièvres Hémorragiques Virales, Cotonou, Benin.

Elisabeth Fichet-Calvet (E)

Virology Department, Bernhard-Nocht Institute for Tropical Medicine, Hamburg, Germany.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH